The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Sponsor: University of Chicago
Listed as NCT01280825, this observational or N/A phase trial focuses on Autoimmune Disease and Blood Coagulation Disorders and remains actively recruiting participants. Sponsored by University of Chicago, it has been updated 18 times since 2011, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
18 versions recorded-
Mar 2026 — Present [monthly]
Recruiting
-
Mar 2025 — Mar 2026 [monthly]
Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 13 earlier versions
-
Apr 2023 — Feb 2024 [monthly]
Recruiting
-
Feb 2022 — Apr 2023 [monthly]
Recruiting
-
Dec 2021 — Feb 2022 [monthly]
Recruiting
-
Feb 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2020 — Nov 2020 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Feb 2020 — Jun 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Chicago
For direct contact, visit the study record on ClinicalTrials.gov .